Nice try, shorty. It's just a standard shelf filing. They have no need for cash right now.
I've been around crme since '04 before the NASDAQ listing.
My memories are a bit fuzzy, but I believe they had completed the final trial and were waitng for word from the FDA (champagne on ice). The FDA gave them an 'approvable' and required one additional trial--the Act V.
Then during Act V there was a death unrelated to the treatment, and the FDA slapped the hold on them.
So I guess it's possible the FDA might approve based on real world results and not require them to re-do Act 5.
They might have met with the FDA in the last few days. The company has always been for sale, so perhaps someone is sniffing around. But those are just guesses.
Keep in mind also that whenever Wolfman comes bashing, the SP doubles.
The Yahoo stats are off. Currently 15 million shares are out, with about half held by insiders and institutions.